Form 4: Clorox Director Breber Pierre R Reports Acquisition of Deferred Stock Units

Sentiment:

SEC Form 4 Filing


Director Pierre R Breber reports acquiring deferred stock units in Clorox through dividend reinvestment and in lieu of quarterly director's fees.

Summary

  • On March 31, 2025, Director Pierre R Breber acquired 178.2683 deferred stock units of Clorox Co.
  • These units were received in lieu of quarterly director's fees.
  • Additionally, on February 14, 2025, Breber acquired 0.6086 deferred stock units through dividend reinvestment.
  • The deferred stock units will be settled 100% in Clorox stock upon the director's retirement or termination of service.
  • Following these transactions, Breber beneficially owns 252.6635 deferred stock units directly.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The transactions reflect standard director compensation practices and dividend reinvestment, indicating confidence in the company's future.

Positives

  • The acquisition of deferred stock units aligns the director's interests with those of the shareholders, as the units will be settled in Clorox stock upon retirement or termination of service.
  • Dividend reinvestment indicates a positive outlook on the company's future performance.

Future Outlook

The deferred stock units will be settled 100% in Clorox stock upon the director's retirement or other termination of service, indicating a long-term alignment with the company's performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common for directors of publicly traded companies. It reflects part of the director's compensation package and participation in dividend reinvestment programs.

Comparison to Industry Standards

  • Director compensation packages often include deferred stock units to align director interests with shareholder value, a common practice among publicly traded companies like Procter & Gamble (PG) and Unilever (UL).
  • Dividend reinvestment programs are also standard, allowing directors to increase their stake in the company over time, similar to programs offered by Colgate-Palmolive (CL) and Kimberly-Clark (KMB).

Related Party Transactions

  • The receipt of deferred stock units in lieu of quarterly director's fees is a related party transaction.

Stakeholder Impact

  • The acquisition of deferred stock units aligns the director's interests with those of the shareholders, potentially leading to decisions that benefit the company's long-term performance.
  • Employees may view this as a positive sign, indicating that leadership is invested in the company's success.

Key Dates

DateDescription
02/14/2025Acquisition of 0.6086 Deferred Stock Units through dividend reinvestment.
03/31/2025Acquisition of 178.2683 Deferred Stock Units in lieu of quarterly director's fees.
04/02/2025Date of signature for the Form 4 filing.

Keywords

Deferred Stock Units, Director Compensation, Dividend Reinvestment, Form 4, Clorox, CLX, Insider Trading

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.